Insulin-like growth factor binding protein-1 (IGFBP-1, pp12), antibody

Cat.# 4I52

This data sheet is provided for information only. After adding the product to the cart by clicking the button below you will see if there is a volume discount available.

Sign up or login to see prices and to request offers

MAbs:
Price:
-- / mg
Login for price
* All prices excluding VAT
Request an offer Samples available
Fertility and pregnancy
  • Cat.#

    4I52

  • MAbs:

    A8, G2

    Hybridoma clones have been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with purified IGFBP-1 from human amniotic fluid.

  • MAb isotypes:

    IgG1 for MAb A8
    IgG2a for MAb G2

  • Applications:

    Antibodies are working in indirect ELISA and Western blotting.

  • Purification:

    Protein G chromatography

  • Presentation:

    PBS, pH 7.4, 0.09 % sodium azide (NaN₃)

  • Storage:

    +4 °C (+2 … +8 °C allowed)

  • Material safety note:

    This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.

    Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.

×

Bulk Price Quotation

You can request quotations by filling in the desired amount and your information. Please note that if you register or login you can see the prices immediately without waiting for quotes. You can also request a sample here.

Insulin-like growth factor binding protein-1 (IGFBP-1, pp12), antibody (MAb: )

Information

×

Sample Request

Insulin-like growth factor binding protein-1 (IGFBP-1, pp12), antibody (MAb: )

Evaluation samples available. You can save up to 50%*

Information

*The usual shipping and handling costs will still apply. The sample opportunity is a one-time evaluation possibility and you can get more details by contacting HyTest customer service.

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!